Back to results
US 2003/0170717 A1Published application
Detection of genes regulated by EGF in breast cancer
AssigneeIncyte Corporation
InventorsMary Faris, David G. Streeter
Life of this patent
Estimating the term…
Abstract
The present invention relates to a combination comprising a plurality of polynucleotide probes that are modulated in response to EGF and which are associated with breast cancer, and which may be used in their entirety or in part as to diagnose, to stage, to treat, or to monitor the treatment of a subject with a breast cancer.
Claims18
A combination comprising a plurality of cDNAs, selected from SEQ ID NOs:1-16 or their complements, whose expression is modulated by EGF and is associated with breast cancer.
An isolated cDNA, or the complement thereof, selected from SEQ ID NOs:12-16.
Dependencies are inferred from the claim text.